Digital support more than doubles the odds it does. We verify that it did, dose by dose, from day 1 of initiation.
A link on any phone. No app, no hardware, no field agents.
Recognitions awarded to Play for Earth, the venture behind Play4Health.
9 randomised trials, more than twice the odds of adherence. Every one of them measured it by asking the patient.
A patient who stops at month 3 of a 12-month therapy takes 9 months of treatment revenue with them, on top of the acquisition spend already made. The support that keeps them has published evidence behind it. What no sponsor can show today is whether it worked in their own cohort. Play4Health supplies that half: photo-confirmed, timestamped, from day 1 of initiation.
Trial populations covered cardiovascular disease, depression, Parkinson's disease, psoriasis and multimorbidity, at moderate evidence quality. Not a forecast for any specific programme, and not a Play4Health result.
Every tool tracks whether the medicine was taken. None track what happens to the device afterwards.
Confirmed in the tool the patient already uses for doses. No parallel programme to fund.
Photo, timestamp and duplicate controls on every return. A counted number.
Returns count alongside dose confirmation. One dataset, not two reports.
We generate the verified return record. Collection and reprocessing stay with your logistics and waste partners.
Dose confirmations, behavior stages, device returns and side-effect signals, across all cohorts.
Patients participate directly. No app, no hardware, no clinic visit.
Dose or device return confirmed from a link. No login friction.
Timeframe rules, duplicate controls and photo context checked instantly.
Streaks and progress signals sustain daily engagement. No cash incentive tied to any prescription decision.
Live and export-ready for PSP and medical affairs reporting.
A percentage tells you doses were missed. The Health Adherence Index tells you who has stopped engaging with the routine, while they are still reachable.
A behavioral signal for programme management. Not a diagnostic tool, and no replacement for clinical judgment.
0 to 100 per patient, refreshed monthly, mapped to 5 stages from Inactive to Internalized. Patients confirm facts, never score themselves.
Any regimen where a missed dose stays invisible until the next appointment. The four we start with.
Taken daily by patients who feel fine. Silent drop-off, discovered at the exacerbation.
Inhaler return loopMultiple inhalers, older patients, complex technique. Hospitalisations track to interrupted therapy.
Inhaler return loopInjection pens, titration and side-effect burden. Discontinuation surfaces months after control is lost.
Pen return loopLong regimens, heavy side effects, resistance as the cost of interruption. Adherence is the outcome.
Adherence only, no device streamWe enter at initiation, because that is where a routine can still be shaped, and we stay for as long as the treatment lasts. Condition-agnostic: all it needs is a near-daily action a patient can confirm, and where a device is involved the return loop runs on the same action. The economics are sharpest on high-cost therapy, where a patient lost early is an immediate loss against an acquisition cost already spent.
Play4Health is pre-commercial. We are selecting the first sponsor programmes now.
Compare the pilot to the revenue you lose when one patient stops early. On high-cost therapy, the comparison is short.
Every contract includes the full system. Only scope changes. Device recovery volumes are reported in both tiers; collection and reprocessing are scoped separately, on their own budget line.
Healthcare without waste.
Better outcomes for patients.
Better outcomes for the planet.
We start with adherence and device returns, because that is where outcomes are real and regulatory pressure is building today.
Start with a free Health Impact Snapshot. We map what your programme could measure, and what it cannot today.
Cited to describe the general pattern of persistence loss after initiation. These are not Play4Health results. No patient cohort has been deployed yet.